Private Equity

Iconic Australian bootmaker R.M.Williams expands its partnership with Bamboo Rose, leveraging AI-powered planning to modernize its global operations.

A new partnership sees Veritone's AI unlock The Washington Post's video vault, aiming to monetize history while protecting journalistic integrity.

IDOC's acquisition of GSRx signals a major strategic move, promising benefits for independent optometrists but raising questions about industry consolidation.

With FDA Breakthrough status for its MASH drug, a new CEO, and a fortified balance sheet, Altimmune is poised to take on serious liver disease and addiction.

The biotech firm accelerates a key trial but faces a partner loss, widening losses, and a CEO search, putting its promising siRNA pipeline at a crossroads.

Struggling manufacturer Highway Holdings acquires a 51% stake in Germany's Regent-Feinbau, a bold move to enter high-value markets and build resilient supply chains.

The burger giant defied economic headwinds in 2025, posting record growth thanks to a key acquisition, new stores, and a focus on affordability.

With $266M and 300MW of secured power, HighBrook Investors is tackling Northern Virginia's data center shortage, signaling a major PE shift.

The strategic acquisition combines B/CORE's rapid tech deployment with Fuel Consulting's two decades of embedded intelligence community expertise.

Select Medical's take-private deal at $16.50/share faces scrutiny as law firms question if shareholders are getting fair value from an insider-led group.

The deal merges Bonterra’s enterprise grantmaking with Deed’s modern employee engagement platform, signaling a major shift in corporate social responsibility.

Shipping giant TORM seeks shareholder approval for a 10M share buyback and a move to a simpler corporate structure, signaling a focus on shareholder value.

A new strategic partnership between AlbaCore and MUFG aims to unlock billions for UK and European infrastructure, offering investors access to stable returns.

German defense tech firm RENK Group reports a record €1.37B revenue, fueled by a 24% surge in its defense business amid global geopolitical tensions.

The Japanese giant is turning period poverty and gender disparity into a business model, using pads and education to unlock new markets in China, Brazil, and Kenya.

Record sales of its Trio® fertilizer fuel a major financial turnaround, as the company makes significant strides in extracting battery-grade lithium.

The company narrows losses and sells a major asset, betting on experiential attractions like the Balloon Museum to revitalize NYC's Seaport district.

Ellington Credit reports a Q4 net loss amid a tough CLO market, yet management sees a major buying opportunity as asset prices get a reality check.

With a unique entry-blocking drug, Bioxytran targets COVID, flu, and RSV, moving toward a pivotal trial that could redefine antiviral treatment.

One10 names tech and analytics veteran Drew Carter its new CEO, signaling a strategic push to fuse motivation science with digital innovation for future growth.